Member Info for Lazarus2

That’s for Company purchase not for single compound licensing

I’m actually referring to the end game purchase price Bobbler. I would totally agree that we will not hit those heights at end of tox. I am speculating that an early buy out might be tempting a pharma if all is good with the science. They would be able to purchase far more cheaply at an earlier stage than waiting for full compound development. Sorry if I hadn’t made that clear enough

Hi Bobbler - I don’t see that any errors Sareum may have made would reflect on the purchase price. The reason I state that is because the trials are monitored and results independently verified so I think the results will drive any perceived value. Any purchaser would immediately take control of either Sareum or its compound. Any deal is not about Sareum business performance. It is all about the science IMO

You are right to remain pragmatic Utah - for now at least. I am of the same opinion as Potnak and PCS. I have long held the view that Sareum is a ready made pipeline for a large pharma. It is just that the science needs to be proven up. No large pharma in its right mind would buy us out as they also have shareholder value to consider. So we must all respect that fact. The Tox study data is vital for Sareum's credibility as it will also have ramifications for 1802. I have thought that the AI collaboration may well have been directed by an interested 3rd party also. For these reasons I think that Sareum is a potential goldmine for us all. I would be surprised if we were not on the radar of the entire Industry and would not be shocked if, on successful completion of 1801 Tox, a pharma made a bid in an attempt to get Sareum on the cheap. By cheap, I mean £5 per share. Of, course, all of this is speculation on my part and just my opinion and wishful thinking maybe, but it is a fact that "potential doesn't last forever" so I am expecting 2026 to be a make or break year for Sareum.

Nice negative thread title there katstrangler. Good post Potnak.

Morning Digitaljunior - I think most on here if not all would find it nigh on impossible to calculate a worth for Sareum due to the broad based pipeline development and speculation surrounding possible license deals or a buyout- even then, the science has to be proven up before deals can take place. SD has been a supportive investor for Sareum and will have formed his own view as to value or target prices. Good luck with any investment you might have. Many of us feel that this year may well be pivotal for Sareum

There she blows!

22p being hit and could be about to pop. Despite resistance

22p being paid - up 19%

Something to stirring for sure. Sareum hasn’t started so strongly for a long time. Maybe the brakes are being released

Full Ask being paid

A few chunkier buys going through around the 17p Ask

*National newspaper

I think most if not all on here appreciate the information but it needs to find its way to the wider investing community for research maybe. A tweet, LinkedIn or newspaper article would help. Meanwhile, we remain cheap as chips.

Tag Teams out in force this morning - guess you’ll all be selling first thing then

It’s a positive RNS with a clear commitment to purchase a second drill and no requirement to raise. In this world of instant comms it takes a few minutes to post and micro seconds to buy/sell shares. Unfortunately the guys on the ground have all sorts of hurdles to overcome. The fact that we are still proving up critical minerals is excellent news going forwards. Get some perspective ffs

Agreed Potnak. Interesting times indeed. I also think there is a growing awareness of Sareum within professional circles. Although that doesn't necessarily translate into investment. All to play for.

I have been pondering about my strategy of researching unloved shares with strong potential. My other shares are in gold and critical minerals so they have something "tangible" even though 2 of them have little or no revenue. Sareum is my exception whereby I have put my faith in the science and the potential for significant returns.

I am encouraged by what appears to be a stellar year lining up in 2026 IF the science is further corroborated and Sareum makes commercial progress/inroads. Oddly, Sareum is my riskiest investment but I feel is the one most likely to blow the doors off as and when. There were setbacks and there may yet be more so this is not intended as advice, but at these current levels, Sareum, as an unloved share, is a gift at these levels. Cash runway is the main drag on the sp along with uncertainty over the trial. If this is addressed, Sareum sp will be significantly higher and recent prices have held steady at this low level. I am sure a few of us LTH's have taken advantage at this level. If we have to go cap in hand to The City, they will have the shirts off of our backs - no doubt. But, oddly enough, this provides an even better opportunity if the science holds up to scrutiny. Conversely, 737 or 1801 could provide a boost to the coffers and we are off to the races so to speak. Don't let frustration diminish the opportunity or cloud the facts. Anyway, tin hat at the ready but I remain confident of a highly significant ROI

Flying out of the traps this morning.

Comprehensive update addressing every aspect of the business plan and progress. Couldn’t ask for more at this stage.